• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与使用胆碱酯酶抑制剂相关的上消化道出血。

Upper gastrointestinal bleed associated with cholinesterase inhibitor use.

作者信息

Kok Khoon-Sheng, Loke Yoon, Southgate Jo

机构信息

Norfolk and Norwich University Hospital, Norwich, UK.

Norwich Medical School, University of East Anglia, Norwich, UK.

出版信息

BMJ Case Rep. 2015 Sep 29;2015:bcr2015211859. doi: 10.1136/bcr-2015-211859.

DOI:10.1136/bcr-2015-211859
PMID:26420698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4593249/
Abstract

An 86-year-old man was admitted with a 3-day history of melaena and syncope. He was haemodynamically compromised and anaemic on presentation. His only medical history was mild Alzheimer's disease diagnosed 6 months prior. For this, he was on donepezil, a cholinesterase inhibitor (ChEI), with a recent dose increase 3 months earlier. After fluid resuscitation with packed red cells, an endoscopy was performed, which showed an acute duodenal ulcer. This was treated with a high-dose proton pump inhibitor. The patient recovered well and was discharged on donepezil with the addition of a gastro-protective proton pump inhibitor. In view of other absent risk factors of upper gastrointestinal haemorrhage, donepezil was the likely causative agent. ChEIs are associated with frequent side effects and increased hospitalisation due to central and peripheral increase in acetylcholine. With this case report, we review the literature of side effects related to ChEIs, where the mechanisms of action, complications and appropriate management are discussed.

摘要

一名86岁男性因黑便和晕厥3天入院。入院时他存在血流动力学不稳定和贫血的情况。他唯一的病史是6个月前被诊断出患有轻度阿尔茨海默病。为此,他正在服用胆碱酯酶抑制剂(ChEI)多奈哌齐,且在3个月前刚增加了剂量。在输注浓缩红细胞进行液体复苏后,进行了内镜检查,结果显示为急性十二指肠溃疡。给予高剂量质子泵抑制剂进行治疗。患者恢复良好,出院时继续服用多奈哌齐,并加用了一种具有胃保护作用的质子泵抑制剂。鉴于不存在其他上消化道出血的危险因素,多奈哌齐可能是致病因素。ChEIs常伴有副作用,且由于中枢和外周乙酰胆碱增加导致住院率上升。通过本病例报告,我们回顾了与ChEIs相关副作用的文献,并讨论了其作用机制、并发症及适当的管理方法。

相似文献

1
Upper gastrointestinal bleed associated with cholinesterase inhibitor use.与使用胆碱酯酶抑制剂相关的上消化道出血。
BMJ Case Rep. 2015 Sep 29;2015:bcr2015211859. doi: 10.1136/bcr-2015-211859.
2
Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors.胆碱酯酶抑制剂治疗的阿尔茨海默病患者中晕厥的意义
Europace. 2003 Oct;5(4):429-31. doi: 10.1016/s1099-5129(03)00080-1.
3
Recurrence of upper gastrointestinal bleeding after donepezil administration.多奈哌齐给药后上消化道出血复发。
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):326. doi: 10.1097/01.wad.0000213851.59119.0b.
4
Cardiovascular effects and risk of syncope related to donepezil in patients with Alzheimer's disease.多奈哌齐对阿尔茨海默病患者的心血管影响及晕厥风险
CNS Drugs. 2006;20(5):411-7. doi: 10.2165/00023210-200620050-00005.
5
Donepezil-induced cervical dystonia in Alzheimer's disease: a case report and literature review of dystonia due to cholinesterase inhibitors.多奈哌齐诱发阿尔茨海默病患者颈部肌张力障碍:一例报告及胆碱酯酶抑制剂所致肌张力障碍的文献综述
Intern Med. 2014;53(9):1007-10. doi: 10.2169/internalmedicine.53.1857. Epub 2014 May 1.
6
Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors.胆碱酯酶抑制剂的药效动力学表明,对于长期使用快速可逆抑制剂治疗的患者,可加用低剂量的碳酰化抑制剂进行辅助治疗。
J Alzheimers Dis. 2014;39(2):423-40. doi: 10.3233/JAD-130845.
7
Causes of syncope in patients with Alzheimer's disease treated with donepezil.使用多奈哌齐治疗的阿尔茨海默病患者晕厥的原因。
Drugs Aging. 2005;22(8):687-94. doi: 10.2165/00002512-200522080-00005.
8
Donepezil and cardiac syncope: case report.多奈哌齐与心源性晕厥:病例报告
Int J Geriatr Psychiatry. 2004 Nov;19(11):1110-2. doi: 10.1002/gps.1183.
9
[Interaction of donepezil with rocuronium].多奈哌齐与罗库溴铵的相互作用
Duodecim. 2012;128(10):1031-2.
10
Safety and tolerability of donepezil, rivastigmine and galantamine for patients with Alzheimer's disease: systematic review of the 'real-world' evidence.治疗阿尔茨海默病患者的多奈哌齐、利斯的明和美金刚的安全性和耐受性:“真实世界”证据的系统评价。
Dement Geriatr Cogn Disord. 2009;28(5):389-403. doi: 10.1159/000255578. Epub 2009 Nov 6.

本文引用的文献

1
Upper gastrointestinal bleeding in elderly adults with dementia receiving cholinesterase inhibitors: a population-based cohort study.
J Am Geriatr Soc. 2014 Feb;62(2):382-4. doi: 10.1111/jgs.12670.
2
Proton pump inhibitors: potential adverse effects.质子泵抑制剂:潜在的不良反应。
Curr Opin Gastroenterol. 2012 Nov;28(6):615-20. doi: 10.1097/MOG.0b013e328358d5b9.
3
Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study.胆碱酯酶抑制剂与因心动过缓住院:一项基于人群的研究。
PLoS Med. 2009 Sep;6(9):e1000157. doi: 10.1371/journal.pmed.1000157. Epub 2009 Sep 29.
4
Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study.痴呆患者使用胆碱酯酶抑制剂时的晕厥及其后果:一项基于人群的队列研究。
Arch Intern Med. 2009 May 11;169(9):867-73. doi: 10.1001/archinternmed.2009.43.
5
Donepezil for the treatment of agitation in Alzheimer's disease.多奈哌齐用于治疗阿尔茨海默病中的激越症状。
N Engl J Med. 2007 Oct 4;357(14):1382-92. doi: 10.1056/NEJMoa066583.
6
Recurrence of upper gastrointestinal bleeding after donepezil administration.多奈哌齐给药后上消化道出血复发。
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):326. doi: 10.1097/01.wad.0000213851.59119.0b.
7
Alzheimer's centennial legacy: origins, landmarks and the current status of knowledge concerning cognitive aspects.阿尔茨海默病百年历程:认知方面的起源、里程碑及当前知识现状
Brain. 2006 Nov;129(Pt 11):2811-22. doi: 10.1093/brain/awl275.
8
Cholinesterase inhibitors for Alzheimer's disease.用于治疗阿尔茨海默病的胆碱酯酶抑制剂。
Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD005593. doi: 10.1002/14651858.CD005593.
9
A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs.一种涉及胆碱酯酶抑制剂和抗胆碱能药物的处方级联反应。
Arch Intern Med. 2005 Apr 11;165(7):808-13. doi: 10.1001/archinte.165.7.808.
10
Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.565例阿尔茨海默病患者的长期多奈哌齐治疗(AD2000):随机双盲试验。
Lancet. 2004 Jun 26;363(9427):2105-15. doi: 10.1016/S0140-6736(04)16499-4.